|
Onnamide A |
0 |
0.55 |
0.46 |
0.51 |
1.0 |
6-Ring:2/2 |
MIBiG |
Source |
C=C1C[C@](OC)([C@H](O)C(=O)N[C@H]2OCO[C@H]3[C@@H]2O[C@H](C[C@H](O)CCC/C=C/C=C/C=C/C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)(C)[C@@H]3OC)O[C@H](C)[C@@H]1C |
view |
Onnamide A |
|
|
kirromycin |
1 |
0.52 |
0.47 |
0.53 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
C/C=C\C=C\[C@@H]1O[C@](O)([C@H](CC)C(=O)NC/C=C/C=C(\C)[C@@H](OC)[C@@H](C)[C@@H]2O[C@H](/C=C/C=C/C=C(C)/C(O)=C3/C(=O)C=CNC3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)C1(C)C |
view |
kirromycin |
|
|
FK520 |
2 |
0.52 |
0.45 |
0.53 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
CC[C@@H]1/C=C(/C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC |
view |
FK520 |
|
|
helvolic acid |
22 |
0.4 |
0.45 |
0.46 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CC(=O)O[C@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@]2(C)C(=O)[C@@H](OC(C)=O)[C@H]2[C@H](C)C(=O)C=C[C@@]23C)/C1=C(\CCC=C(C)C)C(=O)O |
view |
helvolic acid |
|
|
clavaric acid |
23 |
0.4 |
0.45 |
0.46 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)C[C@@H](OC(=O)CC(C)(O)CC(=O)O)C(=O)C(C)(C)[C@@H]1CC3 |
view |
clavaric acid |
|
|
nodularin |
24 |
0.4 |
0.47 |
0.44 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
C/C=C1/C(=O)N[C@@H](C(=O)O)[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](/C=C/C(C)=C/[C@H](C)[C@H](Cc2ccccc2)OC)[C@H](C)C(=O)N[C@@H](C(=O)O)CCC(=O)N1C |
view |
nodularin |
|
|
macrobrevin |
25 |
0.38 |
0.45 |
0.43 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CCC(C)C(O)/C=C/C(C)=C/C=C/C(C)CC(C)C1CC(O)C(C)/C=C\C=C/C(C)C/C=C(/C)C(O)/C=C\CC(O)C(C)/C=C\C(=O)O1 |
view |
macrobrevin |
|
|
meridamycin |
3 |
0.52 |
0.48 |
0.52 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
CC/C1=C/C[C@@H](/C(C)=C/[C@@H](C)[C@@H](C)O)OC(=O)C2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](O)[C@H](C)[C@@H](O)C[C@@H](O)C[C@H](O)/C(C)=C\[C@@H](C)CC(C)[C@@H]1O |
view |
meridamycin |
|
|
Spirangien A1 |
4 |
0.52 |
0.46 |
0.45 |
1.0 |
6-Ring:2/2 |
MIBiG |
Source |
C/C=C(\C)C[C@H](C)[C@H](O)[C@@H](C)[C@H]1O[C@@]2(C[C@@H](OC)[C@H]1C)O[C@H]([C@@H](C)[C@@H](O)[C@@H](C)/C=C\C=C\C=C/C=C/C=C\[C@H](CC(=O)O)OC)[C@@H](C)C[C@@H]2O |
view |
Spirangien A1 |
|
|
tautomycin |
5 |
0.51 |
0.47 |
0.41 |
1.0 |
6-Ring:2/2 |
MIBiG |
Source |
CO[C@@H]([C@H](O)CC(=O)[C@@H](C)[C@@H](O)CC[C@@H](C)[C@@H]1O[C@@]2(CC[C@@H]1C)CC[C@@H](C)[C@H](CC[C@H](C)C(C)=O)O2)[C@H](OC(=O)C[C@@H](O)C1=C(C)C(=O)OC1=O)C(C)C |
view |
tautomycin |
|
|
oligomycin |
6 |
0.51 |
0.51 |
0.38 |
1.0 |
6-Ring:2/2 |
MIBiG |
Source |
CC[C@@H]1/C=C\C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C\C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@@]1(CC[C@@H](C)[C@@H](C[C@H](C)O)O1)[C@@H]2C |
view |
oligomycin |
|
|
salinomycin |
7 |
0.5 |
0.49 |
0.44 |
0.8 |
6-Ring:3/2 |
MIBiG |
Source |
CC[C@@H](C(=O)O)C1CC[C@H](C)[C@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(C=C[C@@H](O)[C@@]4(CC[C@@](C)([C@H]5CC[C@](O)(CC)[C@H](C)O5)O4)O3)[C@H](C)C[C@@H]2C)O1 |
view |
salinomycin |
|
|
concanamycin A |
8 |
0.49 |
0.49 |
0.45 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C\C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C\C=C/[C@@H]2OC)C[C@@H](O)[C@@H]1C |
view |
concanamycin A |
|
|
Bafilomycin B1 |
9 |
0.48 |
0.47 |
0.44 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
CO/C1=C/C(C)=C\[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C\C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O |
view |
Bafilomycin B1 |
|
|
JBIR-100 |
10 |
0.48 |
0.5 |
0.42 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
C/C1=C/C(C)C(O)C(C)C/C(C)=C\C=C/CC(C(C)C(O)C(C)C2(O)CC(OC(=O)/C=C/C(=O)O)C(C)C(C(C)C)O2)OC(=O)\C(C)=C/1 |
view |
JBIR-100 |
|
|
sanglifehrin A |
11 |
0.47 |
0.45 |
0.43 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
CC[C@H]1C[C@H](C)[C@@]2(NC1=O)O[C@@H](C[C@H](O)[C@@H](C)CC/C=C/C=C(\C)[C@@H]1C/C=C\C=C/[C@H](O)[C@H](C)[C@@H](O)[C@@H](CCC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3cccc(O)c3)C(=O)N3CCC[C@H](N3)C(=O)O1)[C@H](C)[C@H](O)[C@@H]2C |
view |
sanglifehrin A |
|
|
nanchangmycin |
12 |
0.47 |
0.45 |
0.41 |
0.8 |
6-Ring:3/2 |
MIBiG |
Source |
CO[C@H]1CC[C@@H](O[C@H]2C[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)/C=C(\C)C(=O)[C@H](C)C[C@H](C)C(=O)O)O4)O3)O[C@]3(O[C@@H]([C@H]4O[C@@](O)(CO)[C@H](C)C[C@@H]4C)C[C@@H]3C)[C@@H]2C)O[C@H]1C |
view |
nanchangmycin |
|
|
chaxamycin B |
13 |
0.46 |
0.45 |
0.58 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CC1=C2NC(=O)/C=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C(/C)C(=O)c3c(O)c(C)cc(c3C1=O)C2=O |
view |
chaxamycin B |
|
|
Kalimantacin A |
14 |
0.45 |
0.46 |
0.55 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
C=C(CCC=CC=CCC(C)CC(=O)CC(O)CNC(=O)C(C)C(C)OC(N)=O)CC(C)CC(C)=CC(=O)O |
view |
Kalimantacin A |
|
|
halstoctacosanolide |
15 |
0.45 |
0.45 |
0.39 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
CCC(O)C(C)C(O)CC(O)C(O)/C=C(\C)CC(C)C1CC(O)C(C)/C=C\C=C/CC(C)C(=O)CC2CCC(C)C(O)(C/C=C(C)\C=C(\C)C(O)C(=O)/C=C(/C)C(=O)O1)O2 |
view |
halstoctacosanolide |
|
|
Dorrigocin B |
16 |
0.44 |
0.45 |
0.55 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)[C@@H](O)/C(C)=C/[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
Dorrigocin B |
|
|
13-epi-Dorrigocin A |
17 |
0.43 |
0.45 |
0.53 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)/C=C(\C)[C@@H](O)[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
13-epi-Dorrigocin A |
|
|
Dorrigocin A |
18 |
0.43 |
0.45 |
0.53 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)/C=C(\C)[C@H](O)[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
Dorrigocin A |
|
|
alpha-lipomycin |
19 |
0.42 |
0.46 |
0.49 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C |
view |
alpha-lipomycin |
|
|
nosperin |
20 |
0.42 |
0.46 |
0.32 |
0.67 |
6-Ring:1/2 |
MIBiG |
Source |
C=C1C[C@](OC)([C@H](O)C(=O)N/C=C/C(CO)[C@@H](O)C(C)C(=O)N2CCC[C@H]2[C@H](O)CC(N)=O)O[C@H](C)[C@@H]1C |
view |
nosperin |
|
|
FD-891 |
21 |
0.41 |
0.45 |
0.49 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CO[C@@H](C)[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)CCC(C)[C@@H]1C/C=C\C=C/CC(O)C2O[C@H]2[C@@H](O)[C@H](C)/C=C(C)\C=C(\C)C(=O)O1 |
view |
FD-891 |
|
|
Erythromycin B |
36 |
0.34 |
0.47 |
0.33 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CC[C@H]1OC(=O)[C@H](C)[C@@H](OC2CC(C)(OC)C(O)C(C)O2)C(C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H]1C |
view |
Erythromycin B |
|
|
Erythromycin C |
37 |
0.34 |
0.46 |
0.33 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CC[C@H]1OC(=O)[C@H](C)[C@@H](OC2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](OC2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O |
view |
Erythromycin C |
|
|
emericellamide B |
38 |
0.34 |
0.46 |
0.33 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CCCCCC[C@H](C)C[C@H](C)[C@H]1OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@@H]1C |
view |
emericellamide B |
|
|
erythromycin |
39 |
0.33 |
0.46 |
0.32 |
0.0 |
6-Ring:0/2 |
MIBiG |
Source |
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O |
view |
erythromycin |
|